Warning: fopen(/home/virtual/enm-kes/journal/upload/ip_log/ip_log_2024-03.txt): failed to open stream: Permission denied in /home/virtual/lib/view_data.php on line 88 Warning: fwrite() expects parameter 1 to be resource, boolean given in /home/virtual/lib/view_data.php on line 89 Long-Term Outcomes Following Thermal Ablation of Benign Thyroid Nodules as an Alternative to Surgery: The Importance of Controlling Regrowth
Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

clarivate
OPEN ACCESS
SEARCH
Search

Articles

Page Path
HOME > Endocrinol Metab > Volume 34(2); 2019 > Article
Review Article
Long-Term Outcomes Following Thermal Ablation of Benign Thyroid Nodules as an Alternative to Surgery: The Importance of Controlling Regrowth
Jung Suk Sim1orcid, Jung Hwan Baek2orcid
Endocrinology and Metabolism 2019;34(2):117-123.
DOI: https://doi.org/10.3803/EnM.2019.34.2.117
Published online: June 24, 2019

1Department of Radiology, Withsim Clinic, Seongnam, Korea.

2Department of Radiology and the Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Corresponding author: Jung Hwan Baek. Department of Radiology and the Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea. Tel: +82-2-3010-4348, Fax: +82-2-476-0090, radbaek@naver.com
• Received: May 5, 2019   • Revised: May 15, 2019   • Accepted: May 22, 2019

Copyright © 2019 Korean Endocrine Society

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 9,631 Views
  • 148 Download
  • 56 Web of Science
  • 60 Crossref
  • 57 Scopus
See the letter "Letter: Long-Term Outcomes Following Thermal Ablation of Benign Thyroid Nodules as an Alternative to Surgery: The Importance of Controlling Regrowth (Endocrinol Metab 2019;34:117-23, Jung Suk Sim et al.)" on page 323.
  • Thermal ablation (TA) procedures, such as radiofrequency ablation and laser ablation, are used for the treatment of benign thyroid nodules. Short-term studies (<2 years) have demonstrated that TA is an effective and safe procedure to improve cosmetic or symptomatic problems. However, studies including a longer follow-up period show that treated thyroid nodules can increase in size after 2 to 3 years. Several studies suggest that this results from regrowth at the undertreated nodule margins. Here, we review current data on regrowth after TA and describe factors related to it and possible approaches to prevent it.
Thermal ablation (TA) procedures, such as radiofrequency ablation (RFA) and laser ablation (LA), are used to treat benign thyroid nodules [12]. Short-term studies (<1 to 2 years) showed that TA is effective and safe for the treatment of cosmetic or symptomatic problems, resulting in a reduction in nodule volume of 50% to 80% [2]. Some authors suggest that the primary purpose of TA is to improve pressure symptoms rather than to provide complete ablation [34]. When LA and RFA were first introduced in the 2000s, this paradigm formed the main strategy for patients who were either unable or unwilling to undergo surgery [56]. As an alternative to surgery, early TA was aimed at relatively short-term palliation due to the poor general condition of the patient when the initial volume of the nodule was relatively small. The goal of TA at that time was to achieve an approximately 50% volume reduction, generally over a 1-year period [3,4]. However, several studies with longer follow-up periods subsequently showed a tendency for the treated thyroid nodules to increase in size after 2 to 3 years [789]. With increasingly widespread awareness of the safety and effectiveness of TA, patients may choose minimally-invasive TA to avoid scarring in the highly-visible anterior neck area and to reduce the risk of hypothyroidism [10111213]. Therefore, to be considered as an alternative to surgery, TA procedures would need to be effective in the treatment of larger nodules and the effects of treatment should be sustainable for longer periods [91415]. With this goal in mind, we have reviewed the issue of regrowth in studies of TA and we describe the factors related to nodule regrowth and strategies to manage this problem.
To date, several TA studies have reported unsatisfactory results related to regrowth and/or the need for further treatment, such as additional TA or surgery (Table 1) [791516,171819,2021]. In their 2009 study of RFA for the treatment of autonomous nodules, Baek et al. [22] reported observations of regrowth of the untreated peripheral regions, and later described this as ‘marginal regrowth’ [8]. However, similar terms, such as regrowth, marginal regrowth, and recurrence are used under different definitions and criteria. Some researchers prefer to use the term ‘recurrence’ while others prefer to use ‘regrowth’ under virtually the same meaning [2324]. Many authors have defined regrowth as an increase in nodule volume >50% over the previously recorded volume [7925]. Others define regrowth as a post-treatment volume greater than the initial nodule volume [16]. Papini et al. [17] used the term ‘partial regrowth’ when the volume was >20% larger than the volume at 1 year after treatment. Authors have also applied the term regrowth to indicate an increase in nodule volume, but without providing quantitative criteria [26].
For this manuscript, we defined nodule regrowth as an increase of >50% over the smallest previously recorded volume. Marginal regrowth is used to describe the phenomenon of regrowth occurring from the undertreated peripheral areas. Most cases of regrowth occur as a result of marginal regrowth.
If the margin of the nodule is insufficiently ablated, regrowth can occur sometime after TA; one 4-year follow-up study reported that solid nodules tended to regrow after 2 years [7]. A follow-up study of up to 7 years after single-session ablation reported that regrowth occurs in 24.1% of cases, at an average of 39 months after RFA [9].
The most common risk factor for marginal regrowth is a large initial nodule volume [1827]. In a study by Wang et al. [24], 16 of 110 patients experienced recurrence 12 months after microwave ablation and the mean initial volume of the nodules showing recurrence was significantly larger than the non-recurring nodules. The ablation technique is considered to be another important factor associated with regrowth. Lim et al. [7] described regrowth occurring from the incompletely-treated peripheral regions and concluded that controlling the peripheral margin of the nodule with a moving-shot technique is important to prevent marginal regrowth. The anatomical location of the nodule should also be considered. Nodules that are too close to critical structures, such as the recurrent laryngeal nerve or carotid sheath, are more likely to undergo regrowth from the viable tissue remaining after incomplete ablation [2829].
According to the 2017 thyroid RFA guidelines developed by the Korean Society of Thyroid Radiology, multiple-session ablation may be required for large nodules [1], and this view has been supported by other authors [1930]. However, there is no consensus about the specific indication or appropriate timing for multiple ablations [2].
Cervelli et al. [31] noted that in nodules with a post-treatment volume >9 mL and a residual viable tissue volume >4 mL, additional ablation should be performed 1 year after treatment when the ablated tissue has become sufficiently fibrotic. They suggested that during the 1-year post-treatment period, the ablated tissues, which are mainly located at the center of the nodule, are absorbed and the marginal residual tissue is at a sufficient thickness to be treated by additional ablation [31]. Huh et al. [30] compared the outcomes between patients undergoing single-session RFA and those receiving additional ablation 1 month later, showing no significant difference in the 1-year follow-up results between the two groups. The lack of effect in Huh's study [30] may be due to the relatively small size of treated nodules and short interval between the first RFA and the additional ablation. At 1-month post-treatment, residual marginal tissue would be thin and additional ablation may, therefore, not be effective.
Recent studies have focused on the need for earlier identification of nodule regrowth. Sim et al. [9] proposed a method of tracking the volume of the nodule after RFA by dividing it into the total volume (Vt), ablated volume (Va), and viable volume (Vv). Because the reduction in Va occurs rapidly in the initial stages after RFA, growth of the Vv may be masked and Vt may be misinterpreted as decreasing. Therefore, measuring the Vv separately is advantageous for identifying earlier signs of regrowth (Fig. 1) [9]. While very few studies have provided evidence for the appropriate timing for additional ablation, assessment of the Va, Vv, and Vt during follow-up can provide a useful indication. When the Vv begins to increase, it is time to consider additional ablation; when the Vv increases and the Va is small, as shown in Fig. 1C, it is an appropriate point to perform additional RFA. However, even if the Vv is increasing, if the Va is rapidly decreasing, it is advisable to delay additional ablation, and ultrasonography follow-up at 1- to 3-month intervals should be conducted. When the rate of increasing Vv exceeds the rate of decreasing Va, additional ablation should be considered.
Other efforts have been made to identify the remaining viable portion of nodules through contrast-enhanced ultrasonography (CEUS). CEUS can be used to detect the undertreated area immediately or shortly (1 month) after TA, enabling prompt delivery of additional treatment [27,32,33,34]. This method is one approach to increasing the ablation ratio, as described in the section below [34].
When the volume of a nodule is too large to completely ablate it in single session of TA, the initial session aims to ablate the nodule tissue as much as possible. The extent of ablation within the Vt, i.e., the ablation ratio, has a significant impact on future volume reduction. Recently, Sim et al. [35] used the term initial ablation ratio (IAR). Ablation ratio is a ratio of the volume of ablated tissue to the total nodule volume. IAR is an ablation ratio calculated shortly after TA. The meaning of IAR is how much did an operator ablate the nodule tissue with TA. Thus, IAR is a quantitative index representing the performance of a TA procedure, in other words, how well an operator did the TA. In their study, they found that the IAR and the volume reduction ratio (VRR) were positively correlated, so that a high VRR was achieved when IAR was high, and 50% VRR could be expected when ≥70% IAR was achieved [35]. Gambelunghe et al. [19] suggested that complete ablation (or a very high percentage of ablation) is essential to achieve a marked reduction in the thyroid nodule. In a high intensity focused ultrasound study of mild Graves' disease, Lang et al. [36] hypothesized that the ablation volume ratio may be a factor in disease relapse.
By contrast, once the volume of the nodule has reduced, it is important to minimize the amount of residual tissue in order to limit regrowth. To achieve this, different techniques and devices are required. Vascular ablation techniques were recently introduced by Park et al. [37], namely, the artery-first ablation technique and the marginal venous ablation technique. The artery-first technique ablates the tumor-feeding artery first to minimize the heat-sink effect and to reduce the possibility of hemorrhage during the procedure. The draining vein, which is primarily located in the margin of the tumor, interferes with the complete ablation of the margin due to the heat-sink effect. Ablation of these veins can lead to complete ablation of the nodule margin. After puncturing a portion of the vein with the electrode, ablation is initiated when air bubbles are formed and flow into the veins. While this occurs, the veins are filled with hot air bubbles and venous flow eventually ceases, retaining white air bubbles in the lumen of the marginal veins. The marginal venous ablation technique is particularly helpful to prevent marginal regrowth (Fig. 2) [37].
When the nodule tissue is close to a critical structure, it is technically difficult to ablate the tissue completely. This situation is common on the medial side, near the recurrent laryngeal nerve, around the carotid sheath where the vagus nerve and sympathetic ganglions are located, and on the posterior side, where anatomical variation occasionally occurs [29]. Therefore, it is helpful to artificially create a margin of safety at these locations. The hydrodissection technique is one method used for this purpose and involves the injection of a fluid, such as 5% dextrose [1]. After the needle is inserted between the nodule and the critical structures, ablation is performed while fluid is continuously injected, or immediately after injecting fluid to form safety margin of ≥5 mm. Using this method, effective ablation can be achieved, thereby minimizing the residual margin of viable tissue [3237].
With greater knowledge of the factors associated with nodule regrowth and strategies to manage this issue, it is possible to improve the clinical outcome of TA by minimizing marginal regrowth. In so doing, it is possible that the outcomes of TA may be comparable to that of surgery.

CONFLICTS OF INTEREST: This study received no funding in the form of grants. Jung Hwan Baek's financial activities are not related to the present article (patent holder of a unidirectional ablation electrode); he has been a consultant to two radiofrequency companies, STARmed and RF Medical, since 2017.

  • 1. Kim JH, Baek JH, Lim HK, Ahn HS, Baek SM, Choi YJ, et al. 2017 Thyroid radiofrequency ablation guideline: Korean Society of Thyroid Radiology. Korean J Radiol 2018;19:632–655. ArticlePubMedPMC
  • 2. Cesareo R, Palermo A, Pasqualini V, Cianni R, Gaspa G, Manfrini S, et al. Radiofrequency ablation for the management of thyroid nodules: a critical appraisal of the literature. Clin Endocrinol (Oxf) 2017;87:639–648. ArticlePubMed
  • 3. Papini E, Guglielmi R, Bizzarri G, Graziano F, Bianchini A, Brufani C, et al. Treatment of benign cold thyroid nodules: a randomized clinical trial of percutaneous laser ablation versus levothyroxine therapy or follow-up. Thyroid 2007;17:229–235. ArticlePubMed
  • 4. Deandrea M, Limone P, Basso E, Mormile A, Ragazzoni F, Gamarra E, et al. US-guided percutaneous radiofrequency thermal ablation for the treatment of solid benign hyperfunctioning or compressive thyroid nodules. Ultrasound Med Biol 2008;34:784–791. ArticlePubMed
  • 5. Pacella CM, Bizzarri G, Guglielmi R, Anelli V, Bianchini A, Crescenzi A, et al. Thyroid tissue: US-guided percutaneous interstitial laser ablation-a feasibility study. Radiology 2000;217:673–677. ArticlePubMed
  • 6. Jeong WK, Baek JH, Rhim H, Kim YS, Kwak MS, Jeong HJ, et al. Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients. Eur Radiol 2008;18:1244–1250. ArticlePubMedPDF
  • 7. Lim HK, Lee JH, Ha EJ, Sung JY, Kim JK, Baek JH. Radiofrequency ablation of benign non-functioning thyroid nodules: 4-year follow-up results for 111 patients. Eur Radiol 2013;23:1044–1049. ArticlePubMedPDF
  • 8. Baek JH, Lee JH, Valcavi R, Pacella CM, Rhim H, Na DG. Thermal ablation for benign thyroid nodules: radiofrequency and laser. Korean J Radiol 2011;12:525–540. ArticlePubMedPMC
  • 9. Sim JS, Baek JH, Lee J, Cho W, Jung SI. Radiofrequency ablation of benign thyroid nodules: depicting early sign of regrowth by calculating vital volume. Int J Hyperthermia 2017;33:905–910. ArticlePubMed
  • 10. Bernardi S, Dobrinja C, Fabris B, Bazzocchi G, Sabato N, Ulcigrai V, et al. Radiofrequency ablation compared to surgery for the treatment of benign thyroid nodules. Int J Endocrinol 2014;2014:934595. ArticlePubMedPMCPDF
  • 11. Radzina M, Cantisani V, Rauda M, Nielsen MB, Ewertsen C, D'Ambrosio F, et al. Update on the role of ultrasound guided radiofrequency ablation for thyroid nodule treatment. Int J Surg 2017;41(Suppl 1):S82–S93. ArticlePubMed
  • 12. Mauri G, Pacella CM, Papini E, Sconfienza LM, Solbiati L. Proceedings of the first Italian conference on thyroid minimally invasive treatments and foundation of the Italian research group for thyroid minimally invasive procedures. Int J Hyperthermia 2018;34:603–605. ArticlePubMed
  • 13. Ha EJ, Baek JH, Kim KW, Pyo J, Lee JH, Baek SH, et al. Comparative efficacy of radiofrequency and laser ablation for the treatment of benign thyroid nodules: systematic review including traditional pooling and bayesian network meta-analysis. J Clin Endocrinol Metab 2015;100:1903–1911. ArticlePubMed
  • 14. Park HS, Baek JH, Choi YJ, Lee JH. Innovative techniques for image-guided ablation of benign thyroid nodules: combined ethanol and radiofrequency ablation. Korean J Radiol 2017;18:461–469. ArticlePubMedPMC
  • 15. Gambelunghe G, Stefanetti E, Colella R, Monacelli M, Avenia N, De Feo P. A single session of laser ablation for toxic thyroid nodules: three-year follow-up results. Int J Hyperthermia 2018;34:631–635. ArticlePubMed
  • 16. Valcavi R, Riganti F, Bertani A, Formisano D, Pacella CM. Percutaneous laser ablation of cold benign thyroid nodules: a 3-year follow-up study in 122 patients. Thyroid 2010;20:1253–1261. ArticlePubMed
  • 17. Papini E, Rago T, Gambelunghe G, Valcavi R, Bizzarri G, Vitti P, et al. Long-term efficacy of ultrasound-guided laser ablation for benign solid thyroid nodules. Results of a three-year multicenter prospective randomized trial. J Clin Endocrinol Metab 2014;99:3653–3659. ArticlePubMed
  • 18. Dossing H, Bennedbaek FN, Hegedus L. Long-term outcome following interstitial laser photocoagulation of benign cold thyroid nodules. Eur J Endocrinol 2011;165:123–128. ArticlePubMed
  • 19. Gambelunghe G, Fede R, Bini V, Monacelli M, Avenia N, D'Ajello M, et al. Ultrasound-guided interstitial laser ablation for thyroid nodules is effective only at high total amounts of energy: results from a three-year pilot study. Surg Innov 2013;20:345–350. ArticlePubMed
  • 20. Spiezia S, Garberoglio R, Milone F, Ramundo V, Caiazzo C, Assanti AP, et al. Thyroid nodules and related symptoms are stably controlled two years after radiofrequency thermal ablation. Thyroid 2009;19:219–225. ArticlePubMed
  • 21. Sung JY, Baek JH, Jung SL, Kim JH, Kim KS, Lee D, et al. Radiofrequency ablation for autonomously functioning thyroid nodules: a multicenter study. Thyroid 2015;25:112–117. ArticlePubMed
  • 22. Baek JH, Moon WJ, Kim YS, Lee JH, Lee D. Radiofrequency ablation for the treatment of autonomously functioning thyroid nodules. World J Surg 2009;33:1971–1977. ArticlePubMedPDF
  • 23. Suh CH, Baek JH, Ha EJ, Choi YJ, Lee JH, Kim JK, et al. Ethanol ablation of predominantly cystic thyroid nodules: evaluation of recurrence rate and factors related to recurrence. Clin Radiol 2015;70:42–47. ArticlePubMed
  • 24. Wang B, Han ZY, Yu J, Cheng Z, Liu F, Yu XL, et al. Factors related to recurrence of the benign non-functioning thyroid nodules after percutaneous microwave ablation. Int J Hyperthermia 2017;33:459–464. ArticlePubMed
  • 25. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 2016;26:1–133. ArticlePubMedPMC
  • 26. Piana S, Riganti F, Froio E, Andrioli M, Pacella CM, Valcavi R. Pathological findings of thyroid nodules after percutaneous laser ablation: a series of 22 cases with cyto-histological correlation. Endocr Pathol 2012;23:94–100. ArticlePubMedPDF
  • 27. Zhao CK, Xu HX, Lu F, Sun LP, He YP, Guo LH, et al. Factors associated with initial incomplete ablation for benign thyroid nodules after radiofrequency ablation: first results of CEUS evaluation. Clin Hemorheol Microcirc 2017;65:393–405. ArticlePubMed
  • 28. Baek JH, Lee JH, Sung JY, Bae JI, Kim KT, Sim J, et al. Complications encountered in the treatment of benign thyroid nodules with US-guided radiofrequency ablation: a multicenter study. Radiology 2012;262:335–342. ArticlePubMed
  • 29. Kim C, Lee JH, Choi YJ, Kim WB, Sung TY, Baek JH. Complications encountered in ultrasonography-guided radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers. Eur Radiol 2017;27:3128–3137. ArticlePubMedPDF
  • 30. Huh JY, Baek JH, Choi H, Kim JK, Lee JH. Symptomatic benign thyroid nodules: efficacy of additional radiofrequency ablation treatment session: prospective randomized study. Radiology 2012;263:909–916. ArticlePubMed
  • 31. Cervelli R, Mazzeo S, De Napoli L, Boccuzzi A, Pontillo-Contillo B, Materazzi G, et al. Radiofrequency ablation in the treatment of benign thyroid nodules: an efficient and safe alternative to surgery. J Vasc Interv Radiol 2017;28:1400–1408. ArticlePubMed
  • 32. Yue WW, Wang SR, Lu F, Sun LP, Guo LH, Zhang YL, et al. Radiofrequency ablation vs. microwave ablation for patients with benign thyroid nodules: a propensity score matching study. Endocrine 2017;55:485–495. ArticlePubMedPDF
  • 33. Mauri G, Cova L, Monaco CG, Sconfienza LM, Corbetta S, Benedini S, et al. Benign thyroid nodules treatment using percutaneous laser ablation (PLA) and radiofrequency ablation (RFA). Int J Hyperthermia 2017;33:295–299. ArticlePubMed
  • 34. Li XL, Xu HX, Lu F, Yue WW, Sun LP, Bo XW, et al. Treatment efficacy and safety of ultrasound-guided percutaneous bipolar radiofrequency ablation for benign thyroid nodules. Br J Radiol 2016;89:20150858. ArticlePubMedPMC
  • 35. Sim JS, Baek JH, Cho W. Initial ablation ratio: quantitative value predicting the therapeutic success of thyroid radiofrequency ablation. Thyroid 2018;28:1443–1449. ArticlePubMed
  • 36. Lang BH, Woo YC, Wong IY, Chiu KW. Single-session high-intensity focused ultrasound treatment for persistent or relapsed Graves disease: preliminary experience in a prospective study. Radiology 2017;285:1011–1022. ArticlePubMed
  • 37. Park HS, Baek JH, Park AW, Chung SR, Choi YJ, Lee JH. Thyroid radiofrequency ablation: updates on innovative devices and techniques. Korean J Radiol 2017;18:615–623. ArticlePubMedPMC
Fig. 1

Ultrasonography of a thyroid nodule: (A) pre-radiofrequency ablation (RFA), (B) 2 months post-RFA, and (C) 9 months post-RFA. (D-F) Diagrams indicate the total volume (Vt), ablated volume (Va), and viable volume (Vv) at these timepoints. Although Vt decreases over time, Vv increased by 2 mL between months 2 and 9, indicating that growth of the residual viable nodule tissue had already begun. In this case, additional RFA was performed 1 month after obtaining the image in C. aThe centrally-located hypoechoic area of ablated tissue is indicated.

enm-34-117-g001.jpg
Fig. 2

(A) An electrode (short arrows) directly ablates the perinodular vein (arrow). Air bubbles are seen inside the venous lumen (arrowheads). (B) After completing venous ablation, compact filling of hot air bubbles is observed (arrowheads).

enm-34-117-g002.jpg
Table 1

Studies Referring to Nodule Regrowth or a Requirement for Multiple Sessions of Thermal Ablation

enm-34-117-i001.jpg

FU, follow-up; VRR, volume reduction ratio; RFA, radiofrequency ablation; LA, laser ablation; NA, not available; ILP, interstitial laser photocoagulation.

Figure & Data

References

    Citations

    Citations to this article as recorded by  
    • From ablation to operation: Unraveling the surgical outcomes and complications of thyroidectomy after radiofrequency ablation
      Mohammad Hussein, Eman Toraih, Peter P. Issa, Mahmoud Omar, Mohamed Aboueisha, Yusef Buti, Chad P. Issa, Aaron L. Albuck, Katherine Cironi, Abdallah S. Attia, Alexandra C. LaForteza, Mohamed Shama, Emad Kandil
      Surgery.2024; 175(1): 146.     CrossRef
    • Radiofrequency Ablation for Benign Nodules and for Cancer, Too?
      Jonathon O. Russell, Kaitlyn M. Frazier
      Otolaryngologic Clinics of North America.2024; 57(1): 83.     CrossRef
    • Clinical Outcomes of Thermal Ablation Re-Treatment of Benign Thyroid Nodules: A Multicenter Study from the Italian Minimally Invasive Treatments of the Thyroid Group
      Stella Bernardi, Valentina Rosolen, Fabio Barbone, Stefano Borgato, Maurilio Deandrea, Pierpaolo De Feo, Laura Fugazzola, Giovanni Gambelunghe, Roberto Negro, Salvatore Oleandri, Giampaolo Papi, Enrico Papini, Francesca Retta, Ruth Rossetto, Daniela Sanso
      Thyroid®.2024;[Epub]     CrossRef
    • An anthropomorphic thyroid phantom for ultrasound‐guided radiofrequency ablation of nodules
      Tim Boers, Wyger Brink, Leonardo Bianchi, Paola Saccomandi, Johan van Hespen, Germen Wennemars, Sicco Braak, Michel Versluis, Srirang Manohar
      Medical Physics.2024; 51(2): 826.     CrossRef
    • The safety and efficacy of radiofrequency ablation in benign pediatric thyroid disease in the US: An initial case series
      Grace S. Kim, Hilary Seeley, Julia Noel, Iram Ahmad, Kara Meister
      Laryngoscope Investigative Otolaryngology.2024;[Epub]     CrossRef
    • Comparison of the Therapeutic Efficacy and Technical Outcomes between Conventional Fixed Electrodes and Adjustable Electrodes in the Radiofrequency Ablation of Benign Thyroid Nodules
      Jae Ho Shin, Minkook Seo, Min Kyoung Lee, So Lyung Jung
      Korean Journal of Radiology.2024; 25(2): 199.     CrossRef
    • If the price is right: Cost-effectiveness of radiofrequency ablation versus thyroidectomy in the treatment of benign thyroid nodules
      Eric J. Kuo, Aaron Oh, Yinin Hu, Catherine M. McManus, James A. Lee, Jennifer H. Kuo
      Surgery.2023; 173(1): 201.     CrossRef
    • Development and validation of a nomogram model for predicting residue of partially cystic thyroid nodules after ultrasound-guided ethanol and thermal ablation
      Di Li, Xiaoer Zhang, Yutong Zhang, Tongyi Huang, Rui Zhang, Wenwen Zhou, Xiaoyan Xie, Ming Xu
      Frontiers in Endocrinology.2023;[Epub]     CrossRef
    • Image-guided Thermal Ablation as a Promising Approach to Both Nontoxic and Toxic Autonomously Functioning Thyroid Nodules
      Long Wang, Peiqing Wang, Zhijiang Chen, Yinghe Lin, Yingshan Liu, Rong Peng, Jinlian Li, Wenfeng Luo, Jian Kuang
      Academic Radiology.2023; 30(11): 2636.     CrossRef
    • Analysis and prediction of regrowth in benign thyroid nodules undergoing radiofrequency ablation: a retrospective study with a 5-year follow-up
      Yi Li, Wen Li, Bo Jiang, Jiahang Zhao, Yan Zhang, Yukun Luo
      European Radiology.2023; 33(8): 5615.     CrossRef
    • Ultrasound (US)-Guided Ablation of Thyroid Nodules
      Byung Seup Kim
      Journal of Surgical Ultrasound.2023; 10(1): 14.     CrossRef
    • Minimally Invasive Ablative Treatments for Benign Thyroid Nodules: Current Evidence and Future Directions
      Enrico Papini, Laszlo Hegedüs
      Thyroid®.2023; 33(8): 890.     CrossRef
    • Ultrasound imaging in thyroid nodule diagnosis, therapy, and follow‐up: Current status and future trends
      Tim Boers, Sicco J. Braak, Nicole E. T. Rikken, Michel Versluis, Srirang Manohar
      Journal of Clinical Ultrasound.2023; 51(6): 1087.     CrossRef
    • Radiofrequency ablation of benign thyroid nodules: the value of anterolateral hydrodissection
      So Yeong Jeong, Jung Hwan Baek, Sae Rom Chung, Young Jun Choi, Ki-Wook Chung, Tae Yong Kim, Jeong Hyun Lee
      Ultrasonography.2023; 42(3): 432.     CrossRef
    • Radiofrequency Ablation for Benign Thyroid Nodules
      Julia E Noel, Catherine F Sinclair
      The Journal of Clinical Endocrinology & Metabolism.2023; 109(1): e12.     CrossRef
    • High-security automatic path planning of radiofrequency ablation for liver tumors
      Jing Li, Huayu Gao, Nanyan Shen, Di Wu, Lanyun Feng, Peng Hu
      Computer Methods and Programs in Biomedicine.2023; 242: 107769.     CrossRef
    • General Principles for the Safe Performance, Training, and Adoption of Ablation Techniques for Benign Thyroid Nodules: An American Thyroid Association Statement
      Catherine F. Sinclair, Jung Hwan Baek, Kathleen E. Hands, Steven P. Hodak, Timothy C. Huber, Iram Hussain, Brian Hung-Hin Lang, Julia E. Noel, Maria Papaleontiou, Kepal N. Patel, Gilles Russ, Jonathon Russell, Stefano Spiezia, Jennifer H. Kuo
      Thyroid®.2023; 33(10): 1150.     CrossRef
    • Clinical Approach for Thyroid Radiofrequency Ablation
      Jung Suk Sim
      Journal of the Korean Society of Radiology.2023; 84(5): 1017.     CrossRef
    • Contrast-enhanced ultrasound is a reliable and reproducible assessment of necrotic ablated volume after radiofrequency ablation for benign thyroid nodules: a retrospective study
      Lin Yan, XinYang Li, Jing Xiao, YingYing Li, Yaqiong Zhu, Hongying He, Yukun Luo
      International Journal of Hyperthermia.2022; 39(1): 40.     CrossRef
    • Nonsurgical Management of Thyroid Nodules: The Role of Ablative Therapies
      Marius N Stan, Maria Papaleontiou, John J Schmitz, M Regina Castro
      The Journal of Clinical Endocrinology & Metabolism.2022; 107(5): 1417.     CrossRef
    • Safety and Efficacy of Ultrasound-Guided Radiofrequency Ablation for Benign Nonfunctional Thyroid Nodules in Children: A Retrospective Study of 62 Patients with Over Four Years of Follow-Up
      Liwen Li, Xinguang Qiu
      Thyroid.2022; 32(5): 525.     CrossRef
    • A Nomogram to Predict Regrowth After Ultrasound-Guided Radiofrequency Ablation for Benign Thyroid Nodules
      Lin Yan, Mingbo Zhang, Xinyang Li, YingYing Li, Yukun Luo
      Frontiers in Endocrinology.2022;[Epub]     CrossRef
    • Radiofrequency Ablation of Solid, Non-Functional Thyroid Nodules
      Michael Douek
      Techniques in Vascular and Interventional Radiology.2022; 25(2): 100821.     CrossRef
    • American Association of Clinical Endocrinology Disease State Clinical Review: The Clinical Utility of Minimally Invasive Interventional Procedures in the Management of Benign and Malignant Thyroid Lesions
      Sina Jasim, Kepal N. Patel, Gregory Randolph, Stephanie Adams, Roberto Cesareo, Edward Condon, Tara Henrichsen, Malak Itani, Maria Papaleontiou, Leonardo Rangel, John Schmitz, Marius N. Stan
      Endocrine Practice.2022; 28(4): 433.     CrossRef
    • The Use of Radiofrequency Ablation for Benign Thyroid Nodules
      Rachel Liou, Catherine McManus, Jennifer Kuo
      VideoEndocrinology.2022; 9(2): 36.     CrossRef
    • A novel parallel overlapping mode for complete ablation of large benign thyroid nodules in a single-session radiofrequency ablation
      Tao Wu, Bowen Zheng, Lei Tan, Tinghui Yin, Yufan Lian, Shicheng Xu, Jin Ye, Jie Ren
      Frontiers in Endocrinology.2022;[Epub]     CrossRef
    • Efficacy and safety of thermal ablation for autonomously functioning thyroid nodules: a systematic review and meta-analysis
      Hyun Jin Kim, Se Jin Cho, Jung Hwan Baek, Chong Hyun Suh
      European Radiology.2021; 31(2): 605.     CrossRef
    • Letter: Twelve-Month Volume Reduction Ratio Predicts Regrowth and Time to Regrowth in Thyroid Nodules Submitted to Laser Ablation: A 5-Year Follow-Up Retrospective Study
      Jung Suk Sim
      Korean Journal of Radiology.2021; 22(2): 291.     CrossRef
    • How to Monitor and Manage Nodule Regrowth after Thermal Ablation of Benign Thyroid Nodules
      Sang Ik Park, Jung Hwan Baek
      Korean Journal of Radiology.2021; 22(2): 293.     CrossRef
    • Non-enhanced ultrasound is not a satisfactory modality for measuring necrotic ablated volume after radiofrequency ablation of benign thyroid nodules: a comparison with contrast-enhanced ultrasound
      Lin Yan, Yukun Luo, Jing Xiao, Lin Lin
      European Radiology.2021; 31(5): 3226.     CrossRef
    • The Adoption of Ultrasound-guided Radiofrequency Ablation of Thyroid Nodules in the United States
      Jennifer H. Kuo, James A. Lee
      Annals of Surgery.2021; 273(1): e10.     CrossRef
    • Radiofrequency ablation of benign thyroid nodules: recommendations from the Asian Conference on Tumor Ablation Task Force
      Eun Ju Ha, Jung Hwan Baek, Ying Che, Yi-Hong Chou, Nobuhiro Fukunari, Ji-hoon Kim, Wei-Che Lin, Le Thi My, Dong Gyu Na, Lawrence Han Hwee Quek, Ming-Hsun Wu, Koichiro Yamakado, Jianhua Zhou
      Ultrasonography.2021; 40(1): 75.     CrossRef
    • Thermal Treatment Options for Benign Thyroid Nodules—The Role of Radio-Frequency Ablation and Laser Therapy
      Erivelto Volpi
      Clinical Thyroidology.2021; 33(1): 17.     CrossRef
    • Residual vital ratio predicts 5-year volume reduction and retreatment after radiofrequency ablation of benign thyroid nodules but not regrowth
      Stella Bernardi, Fabiola Giudici, Giacomo Colombin, Marco Cavallaro, Fulvio Stacul, Bruno Fabris
      International Journal of Hyperthermia.2021; 38(1): 111.     CrossRef
    • Radiofrequency ablation versus reoperation for benign thyroid nodules that developed after previous thyroid surgery
      Lin Yan, Cuiai Deng, Qing Song, Nan Li, Ling Ren, HongYing He, Wen Li, Mingbo Zhang, Yukun Luo
      International Journal of Hyperthermia.2021; 38(1): 176.     CrossRef
    • Letter to the Editor Regarding “Minimally Invasive Treatment for Benign Parathyroid Lesions: Treatment Efficacy and Safety Based on Nodule Characteristics”
      Jung Suk Sim
      Korean Journal of Radiology.2021; 22(5): 861.     CrossRef
    • Unresolved Clinical Issues in Thermal Ablation of Benign Thyroid Nodules: Regrowth at Long-Term Follow-Up
      Jung Suk Sim, Jung Hwan Baek
      Korean Journal of Radiology.2021; 22(8): 1436.     CrossRef
    • Current Status and Challenges of US-Guided Radiofrequency Ablation of Thyroid Nodules in the Long Term: A Systematic Review
      Stella Bernardi, Andrea Palermo, Rosario Francesco Grasso, Bruno Fabris, Fulvio Stacul, Roberto Cesareo
      Cancers.2021; 13(11): 2746.     CrossRef
    • Long-Term Outcomes of Radiofrequency Ablation for Treatment of Cystic Warthin Tumors versus Solid Warthin Tumors
      Chih-Hung Cha, Sheng-Dean Luo, Pi-Ling Chiang, Wei-Chih Chen, Yu-Cheng Tung, Yan-Ye Su, Wei-Che Lin
      International Journal of Environmental Research and Public Health.2021; 18(12): 6640.     CrossRef
    • Comparison of Thermal Ablation and Surgery for Low-Risk Papillary Thyroid Microcarcinoma: A Systematic Review and Meta-Analysis
      Hyun Jin Kim, Se Jin Cho, Jung Hwan Baek
      Korean Journal of Radiology.2021; 22(10): 1730.     CrossRef
    • Long-Term Outcomes of Thermal Ablation for Benign Thyroid Nodules: The Issue of Regrowth
      Jung Suk Sim, Jung Hwan Baek, Rosaria Meccariello
      International Journal of Endocrinology.2021; 2021: 1.     CrossRef
    • Matrix 3D ultrasound-assisted thyroid nodule volume estimation and radiofrequency ablation: a phantom study
      T. Boers, S. J. Braak, M. Versluis, S. Manohar
      European Radiology Experimental.2021;[Epub]     CrossRef
    • Ultrasound-Guided Thermal Ablation of Bethesda IV Thyroid Nodules: A Pilot Study
      Xinyang Li, Yu Lan, Nan Li, Lin Yan, Jing Xiao, Mingbo Zhang, Yukun Luo
      Frontiers in Endocrinology.2021;[Epub]     CrossRef
    • Percutaneous Microwave Ablation for Benign, Symptomatic Thyroid Nodules: Wave of the Future?
      Alaina D. Geary, Frederick Thurston Drake
      World Journal of Surgery.2020; 44(7): 2280.     CrossRef
    • Radiofrequency Ablation Systemization
      Leonardo Guimarães Rangel, Erivelto Martinho Volpi, Jose Higino Steck, Jonathon O. Russell, Ralph P. Tufano
      VideoEndocrinology.2020;[Epub]     CrossRef
    • Twelve-Month Volume Reduction Ratio Predicts Regrowth and Time to Regrowth in Thyroid Nodules Submitted to Laser Ablation: A 5-Year Follow-Up Retrospective Study
      Roberto Negro, Gabriele Greco, Maurilio Deandrea, Matteo Rucco, Pierpaolo Trimboli
      Korean Journal of Radiology.2020; 21(6): 764.     CrossRef
    • Long-Term Results of Thermal Ablation of Benign Thyroid Nodules: A Systematic Review and Meta-Analysis
      Se Jin Cho, Jung Hwan Baek, Sae Rom Chung, Young Jun Choi, Jeong Hyun Lee
      Endocrinology and Metabolism.2020; 35(2): 339.     CrossRef
    • Effectiveness of Injecting Cold 5% Dextrose into Patients with Nerve Damage Symptoms during Thyroid Radiofrequency Ablation
      Min Kyoung Lee, Jung Hwan Baek, Sae Rom Chung, Young Jun Choi, Yu-Mi Lee, Tae Yong Kim, Jeong Hyun Lee
      Endocrinology and Metabolism.2020; 35(2): 407.     CrossRef
    • Vital volume increase versus clinical evaluation as the indication of additional radiofrequency ablation for benign thyroid nodule: a single center retrospective study
      Lin Yan, Yukun Luo, Mingbo Zhang, Jing Xiao
      International Journal of Hyperthermia.2020; 37(1): 777.     CrossRef
    • Five-Year Results of Radiofrequency and Laser Ablation of Benign Thyroid Nodules: A Multicenter Study from the Italian Minimally Invasive Treatments of the Thyroid Group
      Stella Bernardi, Fabiola Giudici, Roberto Cesareo, Giovanni Antonelli, Marco Cavallaro, Maurilio Deandrea, Massimo Giusti, Alberto Mormile, Roberto Negro, Andrea Palermo, Enrico Papini, Valerio Pasqualini, Bruno Raggiunti, Duccio Rossi, Luca Maria Sconfie
      Thyroid.2020; 30(12): 1759.     CrossRef
    • A practical pretreatment planning method of multiple puncturing for thermal ablation surgery
      Jing Li, Yuanqi Xu, Nanyan Shen, Lanyun Feng, Zhuang Ran, Zongqian Deng
      Biocybernetics and Biomedical Engineering.2020; 40(4): 1469.     CrossRef
    • Radiofrequency for benign and malign thyroid lesions
      Leonardo Rangel, Leonardo M. Volpi, Elaine Stabenow, Jose Higino Steck, Erivelto Volpi, Jonathon O. Russell, Ralph P. Tufano
      World Journal of Otorhinolaryngology - Head and Neck Surgery.2020; 6(3): 188.     CrossRef
    • Residual vital ratio: predicting regrowth after radiofrequency ablation for benign thyroid nodules
      Lin Yan, Yukun Luo, Fang Xie, Mingbo Zhang, Jing Xiao
      International Journal of Hyperthermia.2020; 37(1): 1139.     CrossRef
    • Thermal Ablation of Benign Thyroid Nodules and Papillary Thyroid Microcarcinoma
      Xiao-Wan Bo, Feng Lu, Hui-Xiong Xu, Li-Ping Sun, Kun Zhang
      Frontiers in Oncology.2020;[Epub]     CrossRef
    • Inter-observer reliability in ultrasound measurement of benign thyroid nodules in the follow-up of radiofrequency ablation: a retrospective study
      Lin Yan, Yukun Luo, Qing Song, Nan Li, Jing Xiao, Ying Zhang, Yaqiong Zhu
      International Journal of Hyperthermia.2020; 37(1): 1336.     CrossRef
    • CT-based quantitative evaluation of the efficacy after radiofrequency ablation in patients with benign thyroid nodules
      Yangsean Choi, So-Lyung Jung, Jinhee Jang, Na-Young Shin, Kook-Jin Ahn, Bum-soo Kim
      International Journal of Hyperthermia.2020; 37(1): 742.     CrossRef
    • 2020 European Thyroid Association Clinical Practice Guideline for the Use of Image-Guided Ablation in Benign Thyroid Nodules
      Enrico Papini, Hervé Monpeyssen, Andrea Frasoldati, Laszlo Hegedüs
      European Thyroid Journal.2020; 9(4): 172.     CrossRef
    • Efficacy of Percutaneous Thermal Ablation of Papillary Thyroid Carcinoma
      Ettore Caruso, Ettore Gagliano, Gianlorenzo Dionigi
      Journal of Endocrine Surgery.2019; 19(4): 154.     CrossRef
    • Response: Long-Term Outcomes Following Thermal Ablation of Benign Thyroid Nodules as an Alternative to Surgery: The Importance of Controlling Regrowth (Endocrinol Metab 2019;34:117–23, Jung Suk Sim et al.)
      Jung Suk Sim, Jung Hwan Baek
      Endocrinology and Metabolism.2019; 34(3): 325.     CrossRef
    • Letter: Long-Term Outcomes Following Thermal Ablation of Benign Thyroid Nodules as an Alternative to Surgery: The Importance of Controlling Regrowth (Endocrinol Metab 2019;34:117-23, Jung Suk Sim et al.)
      Tae Yong Kim
      Endocrinology and Metabolism.2019; 34(3): 323.     CrossRef

    Figure

    Endocrinol Metab : Endocrinology and Metabolism